Lactose (India) Limited (BOM:524202)
India · Delayed Price · Currency is INR 99.90
+1.90 (1.94%)
At close: Jan 23, 2026
Lactose (India) Company Description
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally.
The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms.
It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic.
In addition, the company exports its products. Lactose (India) Limited was incorporated in 1991 and is headquartered in Mumbai, India.
Lactose (India) Limited
| Country | India |
| Founded | 1991 |
| Industry | Pharmaceutical Preparations |
| Employees | 140 |
| CEO | Atul Maheshwari |
Contact Details
Address: Unit No. G-02, ‘A’ Wing Mumbai, 400015 India | |
| Phone | 91 22 3513 1864 |
| Website | lactoseindialimited.com |
Stock Details
| Ticker Symbol | 524202 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Atul Maheshwari | Chief Executive Officer |
| Sangita Maheshwari | Chief Financial Officer |
| Ranjit Kshirsagar | Chief Operating Officer |